Fludarabine Tablet Manufacturer, Exporter & Global Supplier

Fludarabine Tablet is a highly effective chemotherapeutic medicine used primarily for the treatment of hematological malignancies such as chronic lymphocytic leukemia (CLL) and indolent non-Hodgkin’s lymphoma (NHL). It belongs to the class of purine analogs that inhibit DNA synthesis, leading to the death of rapidly dividing malignant cells. As a trusted Fludarabine Tablet Manufacturer, we ensure that each tablet is manufactured under strict quality standards, offering safety, efficacy, and consistent therapeutic outcomes.

About Fludarabine Tablet

Fludarabine Tablets provide convenient oral chemotherapy for patients, reducing the need for frequent hospital visits while maintaining therapeutic potency. The active ingredient, Fludarabine phosphate, works by interfering with DNA and RNA synthesis in cancerous lymphocytes, preventing cell replication and inducing apoptosis. As a leading Fludarabine Tablet Manufacturer in India, we comply with WHO-GMP and ISO-certified standards to deliver premium-quality tablets. Additionally, as a Fludarabine Tablet exporter and global supplier, we cater to hospitals, oncology centers, and pharmacies worldwide.

Key Uses of Fludarabine Tablet

• Treatment of chronic lymphocytic leukemia (CLL) in adults

• Management of indolent non-Hodgkin’s lymphoma (NHL)

• Used in combination chemotherapy regimens for hematologic malignancies

• Treatment for patients refractory or relapsed after previous chemotherapy

• Supportive therapy under oncologist supervision for bone marrow or stem cell transplantation

As a responsible Fludarabine Tablet Manufacturer, we ensure that each batch of tablets meets rigorous quality control standards for effectiveness and patient safety.

Dosage and Administration

Fludarabine Tablets are taken orally, with or without food, under the guidance of a healthcare professional. The dosage is determined based on the patient’s body surface area, disease type, and treatment history. It is crucial to follow the prescribed schedule to achieve optimal results. Being a certified Fludarabine Tablet Manufacturer, we provide precise labeling and detailed instructions to support safe and effective use.

Precautions

As a reliable Fludarabine Tablet Manufacturer, we emphasize the following precautions:

• Only use under medical supervision in oncology settings

• Patients with renal or hepatic impairment may require dosage adjustment

• Avoid in individuals with active infections due to immunosuppressive effects

• Inform your physician about other medications to prevent drug interactions

• Pregnant or breastfeeding women should only use Fludarabine under specialist guidance

Possible Side Effects

Fludarabine Tablets may cause side effects, though not all patients experience them. Common side effects include:

• Bone marrow suppression resulting in anemia, leukopenia, or thrombocytopenia

• Fatigue, weakness, or fever due to reduced immunity

• Nausea, vomiting, or diarrhea

• Rare neurological effects such as confusion or peripheral neuropathy

• Allergic reactions including rashes, itching, or swelling

As a transparent Fludarabine Tablet Manufacturer, we provide full information to healthcare providers to manage side effects and ensure patient safety.

Why Choose Us?

• WHO-GMP & ISO-certified Fludarabine Tablet Manufacturer in India

• Recognized exporter and global supplier of oncology solutions

• High-quality oral formulations for hospital and clinical use

• Competitive pricing without compromising safety or efficacy

• Expertise in bulk production, third-party manufacturing, and contract supply

As a leading Fludarabine Tablet Manufacturer, we aim to make high-quality oral chemotherapy accessible and reliable, supporting oncologists and patients worldwide in the fight against blood cancers.

Global Distribution Network

With a strong logistics and compliance framework, we successfully export Fludarabine Tablet to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.